Abstract
Abstract. Two‐hundred‐and‐fifty‐nine strains of Vibrio anguillarum isolated from diseased cultured ayu, Plecoglossus altivelis in various districts of Japan from 1974 to 1977 were studied for their sensitivity to 12 different chemotherapeutic agents: chloramphenicol (CM), tetracycline (TC), streptomycin (SM), kanamycin (KM), aminobenzyl penicillin (ABP), colistin (CL), nalidixic acid (NA), oxolinic acid (OA), piromidic acid (PA), furazolidone (NF), sulpharaonomethoxine (SA) and trimethoprim (TMP). One‐hundred‐and‐thirty‐four of the strains were additionally tested for sensitivity to O/129(2,4‐diamino‐6,7‐diisopropyl pteridine) and ormethoprim (OMP). All strains were susceptible to SM, KM and ABP and also highly sensitive to CL. A correlation of resistance was found among the chemically‐related drugs NA, OA and PA, and TMP, OMP and O/129, Nine strains were sensitive to all the drugs tested. The remaining 250 strains were resistant to various combinations of six drugs (CM, TC, NA, NF, SA and TMP). In particular, strains resistant to NA and NF (20.1%), to CM, TC, SA, NA and NF (29.7%) and to all six drugs (28.2%) were frequently detected. NA‐ or NF‐resistant strains have increased since 1974 and TMP‐resistant strains have increased since 1976. Transferable R plasmids were detected in 165 out of 250 resistant strains. The most common type of R plasmid determined resistance to CM, TC and SA. These multiple drug‐resistant strains with transferable R plasmids were isolated from many different districts.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.